» Authors » Matthew H Abramson

Matthew H Abramson

Explore the profile of Matthew H Abramson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 19
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Abramson M, Sathick I, Knezevic A, Perales M, Jaimes E
Kidney360 . 2024 Oct; PMID: 39446483
Background: Acute kidney injury (AKI) is a common complication of allogeneic hematopoietic cell transplantation (allo-HCT) that increases the risk of mortality. In contrast, higher diversity of intestinal microbiota at the...
2.
Gupta S, Glezerman I, Hirsch J, Wells S, Chen K, Seitter R, et al.
Nephrol Dial Transplant . 2024 Oct; 40(2):405-408. PMID: 39415423
No abstract available.
3.
Gupta S, Glezerman I, Hirsch J, Chen K, Devaraj N, Wells S, et al.
BMJ . 2024 Mar; 384:e077169. PMID: 38538012
Objective: To develop and externally validate a prediction model for severe cisplatin associated acute kidney injury (CP-AKI). Design: Multicenter cohort study. Setting: Six geographically diverse major academic cancer centers across...
4.
Adegbite B, Abramson M, Gutgarts V, Musteata F, Chauhan K, Muwonge A, et al.
Clin J Am Soc Nephrol . 2023 Jun; 18(9):1175-1185. PMID: 37382967
Background: Dasatinib has been associated with nephrotoxicity. We sought to examine the incidence of proteinuria on dasatinib and determine potential risk factors that may increase dasatinib-associated glomerular injury. Methods: We...
5.
Adegbite B, Abramson M, Gutgarts V, Musteata M, Chauhan K, Muwonge A, et al.
medRxiv . 2023 May; PMID: 37131844
Introduction: Dasatinib has been associated with nephrotoxicity. We sought to examine the incidence of proteinuria on dasatinib and determine potential risk factors that may increase dasatinib-associated glomerular injury. Methods: We...
6.
Abramson M, Gutgarts V, Zheng J, Maloy M, Ruiz J, Scordo M, et al.
Clin J Am Soc Nephrol . 2021 Jun; 16(9):1318-1327. PMID: 34135023
Background And Objectives: AKI is a major complication of allogeneic hematopoietic stem cell transplantation, increasing risk of nonrelapse mortality. AKI etiology is often ambiguous due to heterogeneity of conditioning/graft versus...